Related Experiment Videos
Selectin ligands: will the real ones please stand up?
1UCSD Cancer Center, University of California, San Diego, La Jolla 92093, USA. avarki@ucsd.edu
The Journal of Clinical Investigation
|January 15, 1997
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Metabolic radiolabeling of animal cell glycoconjugates.
Current protocols in immunology·2008
Overview of glycoconjugate analysis.
Current protocols in protein science·2008
Metabolic radiolabeling of animal cell glycoconjugates.
Current protocols in protein science·2008
Analysis of monosaccharides.
Current protocols in molecular biology·2008
Metabolic radiolabeling of animal cell glycoconjugates.
Current protocols in molecular biology·2008
Analysis of oligosaccharide negative charge by anion-exchange chromatography.
Current protocols in molecular biology·2008
Endocardial transcription factor HAND2 orchestrates hypoxic and TGF-β signaling to modulate coronary artery formation.
The Journal of clinical investigation·2026
Non-canonical mTORC1-TFEB activation promotes hepatocyte plasticity and high-grade malignancy in hepatocellular carcinoma.
The Journal of clinical investigation·2026
Systems genetics approaches model the heritable architecture of polyendocrine metabolic ovarian syndrome.
The Journal of clinical investigation·2026
Tissue-specific clustering of genetic correlations across autoimmune diseases in a nationwide sibling study.
The Journal of clinical investigation·2026
LINGO1-targeted antibody-drug conjugates improve efficacy and tolerability of antineoplastic therapies in Ewing sarcoma models.
The Journal of clinical investigation·2026
The cGAS/STING pathway in cancer: translating innate DNA sensing into therapeutic potential.
The Journal of clinical investigation·2026
A novel flavonoid derivative for treating colorectal cancer by suppressing tumor angiogenesis through VEGFR2 inhibition.
Journal of advanced research·2026
Latest developments in small molecule inhibitors of cysteine protease B as antileishmanial drugs.
Future medicinal chemistry·2026